contractor articles (662)
Active Articles:
None to display.Retired Articles:
A13063: J9212: InterferonA13065: J1440: G-CSF (Filgrastim, Neupogen)
A13066: J0640: Leucovorin (Wellcovorin)
A13067: J0636: Vitamin D Analogs in Chronic Renal Disease
A13068: J0585: Botulinum Toxin Type A (Botox)
A13069: J0001: Self-Administered Drugs
A13070: G0108: Diabetes Outpatient Self-Management Training
A13071: DYSPHRT: Dysphagia/Swallowing Diagnosis and Therapy
A13072: C9119: Pegfilgrastim (Neulasta)
A13073: C1300: Hyperbaric Oxygen Therapy (HBO Therapy)
A13074: A0434: Specialty Care Transport
A13075: A0430: Air Ambulance Services
A13076: A0425: Ground Ambulance Services
A13077: 97010: Physical Medicine and Rehabilitation
A13080: 95934: H-Reflex Study
A13082: 93922: Noninvasive Physiologic Studies of Upper or Lower Extremity Arteries
A13083: 78300: Bone and/or Joint Imaging
A13084: 64550: Application of Surface (Transcutaneous) Neurostimulator
A13086: 36515: Protein A Column Apheresis (Prosorba)
A13087: 29540: Strapping
A13094: 2003 April Update to the Laboratory National Coverage Determination Software
A13095: Intestinal and Multi-Visceral Transplants
A13097: Deep Brain Stimulation for Essential Tremor and Parkinson's Disease
A13099: Clarification Regarding Nonphysician Practitioners Billing on Behalf of Diabetes Self-Management Training
A13100: Hyperbaric Oxygen Therapy for the Treatment of Diabetic Wounds of the Lower Extremities
A13101: Restating Guidelines for Peripheral Neuropathy with Loss of Protective Sensation in People with Diabetes
A13102: Noncoverage of Multiple Electroconvulsive Therapy
A13103: Neuromuscular Electrical Stimulation
A13104: Electrical Stimulation for the Treatment of Wounds
A13105: 29540: Strapping
A13106: 53850: Prostate Treatments
A13108: 61885: Vagus Nerve Stimulation
A13111: 70450: Computerized Tomography Scans
A13116: 72192: Computerized Tomography of the Pelvis
A13117: 74150: Computerized Axial Tomography of the Abdomen
A13119: 77280: Therapeutic Radiology Simulation-Aided Field Setting
A13122: 77300: Basic Radiation Dosimetry Calculation
A13123: 80100 Qualitative Drug Screen
A13126: 93965: Non-Invasive Evaluation of Extremity Veins
A13129: C1305: Apligraf (Graftskin)
A13130: Fulvestrant (Faslodex)
A13132: G0108: Diabetes Outpatient Self-Management Training
A13135: G0245: Peripheral Neuropathy with Loss of Protective Sensation (LOPS) in People with Diabetes
A13136: G0262: Wireless Capsule Endoscopy
A13138: J2430: Pamidronate (Aredia, APD)
A13140: J9999: Antineoplastic Drugs
A13143: MAHD/ER: Metabolically Active Human Dermal/Epidermal Replacements
A13145: Oxaliplatin (Eloxatin)
A13147: 64550: Application of Surface (Transcutaneous) Neurostimulator
A13151: Coverage and Billing for Percutaneous Image-Guided Breast Biopsy
A13152: 10060: Incision and Drainage of Abscess of Skin, Subcutaneous and Accessory Structures
A13154: 20974: Osteogenic Stimulation
A13155: 29540: Strapping
A13158: 67221: Ocular Photodynamic Therapy (OPT) with Verteporfin
A13159: 70544: Magnetic Resonance Angiography (MRA)
A13161: 78460: Myocardial Perfusion Imaging
A13162: 85651: Sedimentation Rate, Erythrocyte
A13163: 87536: HIV-1 Viral Load Testing
A13165: 92567: Tympanometry
A13166: 93025: Microvolt T-wave Alternans
A13168: 93724: Electronic Analysis of Pacemaker System and Pacer Cardioverter-Defibrillator
A13170: VISCO: Viscosupplementation Therapy for Knee
A13173: Intracoronary (Intravascular) Brachytherapy
A13175: G0030: Positron Emission Tomography (PET) Scans
A13176: J1561: Intravenous Immune Globulin
A13177: J1745: Infliximab (Remicade)
A13179: J9212: Interferon
A13181: J9999: Antineoplastic Drugs
A13186: Claim Processing Requirements for Clinical Diagnostic Laboratory Services Based on the Negotiated Rulemaking
A13640: Medical Nutrition Therapy Services for Beneficiaries with Diabetes or Renal Disease--Policy Change
A14904: 55700: Biopsy of Prostate using Image Guidance--New Policy
A14905: 73218: Magnetic Resonance Imaging of Upper Extremity--New Policy
A14906: 70540: Magnetic Resonance Imaging of the Orbit, Face and Neck--New Policy
A14907: 90804: Interactive Psychotherapy--New Policy
A14908: 90853: Group Psychotherapy--New Policy
A14909: 90810: Interactive Individual Psychotherapy--New Policy
A14910: 90857: Interactive Group Psychotherapy--New Policy
A14911: 92506: Speech--Language Pathology Services--New Policy
A14912: 96000: Comprehensive Motion Analysis Studies--New Policy
A14913: AOOS: Outpatient Observation Services--New Policy
A14915: J1955: Levocarnitine (Carnitor, L-caritine)--New Policy
A14916: 11600: Excision of Malignant Skin Lesions--Addition to Policy
A14918: 70551: Magnetic Resonance Imaging of the Brain--Addition to Policy
A14920: 72141: Magnetic Resonance Imaging of the Spine--Addition to Policy
A14922: 70544: Magnetic Resonance Angiography (MRA)--Addition to Policy
A14926: 72192: Computed Tomography of the Pelvis--Addition to Policy
A14927: 74150: Computed Tomography of the Abdomen--Addition to Policy
A14928: 78267: Breath Test for Helicobacter Pylori (H. PYLORI)--Revision to Policy
A14930: 93350: Stress Echocardiography--Addition to Policy
A14932: 93784: Ambulatory Blood Pressure Monitoring (ABPM)--Addition to Policy
A14934: C9119: Pegfilgrastim (Neulasta)--Revision to Policy
A14936: J0150: Adenosine (Adenocard, Adenoscan)--Revision to Policy
A14937: G0245: Peripheral Neuropathy with Loss of Protective Sensation (LOPS) in People with Diabetes--Revision to Policy
A14939: J1563: Intravenous Immune Globulin--Revision to Policy
A14941: J1950: Leuprolide Acetate--Revision to Policy
A14943: J9999: Antineoplastic Drugs--Revision to Policy
A14944: Q0136: Non-ESRD Epoetin (Procrit)--Revision to Policy
A14945: Q9920: Chronic Renal Failure Erythropoietin (EPOGEN)--Revision to Policy
A14946: Medicare Payment for Uterine Artery Embolization
A14947: Hand Carried Ultrasound (Hand Held Ultrasound)
A14948: Investigational Device Exemption Revised Requirements
A14949: 77417: Therapeutic Radiology Port Film--Widespread Probe Review Referral
A14950: Ambulatory Payment Classification (APC) codes 0610, 0611, and 0612
A14951: Ambulatory Blood Pressure Monitoring--Revision to National Coverage Determination
A14952: October 2003 Update to the Laboratory National Coverage Determination Edit Software
A14953: July 2003 Update to the Laboratory National Coverage Determination Edit Software
A14954: Revision to Coverage of Hyperbaric Oxygen Therapy for the Treatment of Diabetic Wounds of the Lower Extremities
A14955: Diagnosis Code for Screening Pap Smear and Pelvic Examination Services
A14956: Psychiatric Diagnostic Interview Examination--Telehealth Services
A14957: Expanded Coverage of Positron Emission Tomography Scans
A14958: Revision to Electrical Stimulation for the Treatment of Wounds
A14959: 76536: Ultrasound, Soft Tissues of Head and Neck--New Policy
A14960: J0880: Darbepoetin alfa (Aranesp)(novel erythropoiesis stimulating protein [NESP])--New Policy
A19660: Ambulatory Blood Pressure Monitoring
A19661: Treatment of Actinic Keratosis
A19662: 44388: Colonoscopy--Addition to Policy
A19663: 87086: Urine Bacterial Culture--Addition to Policy
A19664: 71250: Computerized Axial Tomography of the Thorax--Addition to Policy
A19665: 82378: Carcinoembryonic Antigen (CEA)--Addition to Policy
A19666: J9999: Antineoplastic Drugs--Addition to Policy
A19668: PHPPROG: Documentation Requirements for Certification/Recertification of Psychiatric Partial Hospitalization Services--Revision to Policy
A19669: Medicare Sets its Sights on Healthy Eyes
A19670: Diagnosis and Treatment of Peripheral Neuropathy with Loss of Protective Sensation in People with Diabetes
A19671: 72192: Computerized Tomography of the Pelvis--Correction to Article
A19672: 84436: Thyroid Function Tests--Addition to Policy
A19673: 84100: Serum Phosphorus
A19674: 85651 Sedimentation Rate, Erythrocyte--Addition to Policy
A19675: 94010: Spirometry--Addition to Policy
A19676: 87086: Urine Bacterial Culture--Revision to Policy
A19677: 94240: Functional Residual Capacity or Residual Volume--Addition to Policy
A19678: 97003: Occupational Therapy Policy for Rehabilitation Services--Addition to Policy
A19679: J9999: Antineoplastic Drugs--Addition to Policy
A20262: Intravenous Immune Globulin for the Treatment of autoimmune Mucocutaneous Blistering Diseases
A20263: Payment for Services Furnished by Audiologists
A20265: 82728: Serum Ferritin--Revision to Policy
A20266: 87086: Urine Bacterial Culture--Addition to Policy
A20267: 94010: Spirometry--Revision to Policy
A20268: 71010: Chest X-ray--Revision to Policy
A20270: 83540: Iron--Revision to Policy
A20271: 93975: Duplex Scanning--Addition to Policy
A20272: 94240: Functional Residual Capacity or Residual Volume--Revision to Policy
A20273: 94642: Aerosolized Pentamidine Isethionate--Revision to Policy
A20274: 94760: Noninvasive Ear or Pulse Oximetry for Oxygen Saturation--Additions to Policy
A20275: 94620: Pulmonary Stress Test--Revision to Policy
A20276: 64664: Diagnostic Aerosol or Vapor Inhalation--Revision to Policy
A20277: 95900: Nerve Conduction Studies--Revision to Policy
A20278: J1561: Intravenous Immune Globulin--Revision to Policy
A20279: J9999: Antineoplastic Drugso--Additions to Policy
A20315: Coverage and Billing for Percutaneous Image-Guided Breast Biopsy
A20316: 20974: Osteogenic Stimulation--Addition to Policy
A20319: 29540: Strapping--Addition to Policy
A20320: 67221: Ocular Photodynamic Therapy (OPT) with Verteporfin
A20321: 70544: Magnetic Resonance Angiography (MRA)--Revision to Policy
A20322: 78460: Myocardial Perfusion Imaging--Revision to Policy
A20323: 85651: Sedimentation Rate, Erythrocyte--Addition to Policy
A20324: 87536: HIV-1 Viral Load Testing--Revision to Policy
A20325: 92567: Tympanometry--Addition to Policy
A20326: 93025: Microvolt T-wave Alternans--Addition to Policy
A20327: 93724: Electronic Analysis of Pacemaker System and pacer Cardioverter-Defibrillator--Revision to Policy
A20329: G0030: Positron Emission Tomography (PET) Scans
A20331: J1561: Intravenous Immune Globulin
A20333: J1745: Infliximab (Remicade)--Addition to Policy
A20335: J9212: Interferon--Revision to Policy
A20339: J9999: Ahntineoplastic Drugs--Revision to Policy
A20340: VISCO: Viscosupplementation Therapy for Knee--Revision to Policy
A20341: Intracoronary (Intravascular) Brachytherapy
A20351: 36245: Extracardiac Arteriography Associated and Billed with Primary Cardiac Catheterizations
A20352: 70540: Widespread Probe Review
A20353: 76375 Widespread Probe Review
A20354: 90857: Widespread Probe Review
A20355: 92507 and 92508 Widespread Probe Review
A20356: 97112, 97530; and 97140, 97535 Widespread Probe Review
A20357: Skilled Nursing Facility Demand Bills
A20358: Psychotropic Drug Use in Skilled Nursing Facilities
A20359: Screening Glaucoma Services
A21136: Payment for Air Ambulance Transportation of Deceased Beneficiary
A21137: Medical Nutrition Therapy Services for Beneficiaries with Diabetes or Renal Disease
A21138: Positron Emission Tomography Scans--Requirements for Breast Cancer and Revised Coverage Conditions for Myocardial Viability
A21139: Rehabilitation Services for Beneficiaries with Vision Impairment
A21142: Revision to HCPCS Codes for Diagnosis and Treatment of Peripheral Neuropathy
A21390: 90901: Biofeedback--New Policy
A21391: G0237: Respiratory Therapeutic Services--New Policy
A21393: 33215: Implantation of Automatic Defibrillators--Addition to Policy
A21394: 43235: Diagnostic and Therapeutic Esophagogastroduodenoscopy--Addition to Policy
A21395: 70544: Magnetic Resonance Angiography (MRA)--Revision to Policy
A21396: 95900: Nerve Conduction Studies--Addition to Policy
A21397: C1300 Hyperbaric Oxygen Therapy (HBO Therapy)--Revision to Policy
A21398: EPO: Epoetin alfa (Formerly Q0136: Epoetin (Procrit) and Q9920: Chronic Renal Failure Erythropoietin (Epogen)--Revision to Policy
A21399: G0030: Positron Emission Tomography (PET) Scan--Revision to Policy
A21400: G0248: Home Prothrombin Time International Normalized Ratio (INR) Monitoring--Addition to Policy
A21402: J0150: Adenosine (Adenocard, Adenoscan)--Correction to Previously Published Article
A21403: J0207: Amifostine (Ethyol)--Addition to Policy
A21404: J0640: Leucovorin (Wellcovorin)--Revision to Policy
A21405: J2355: Oprelvekin (Neumega)--Addition to Policy
A21406: J9999: Antineoplastic Drugs--Addition to Policy
A21407: VISCO: Viscosupplementation Therapy for Knee--Addition to Policy
A21408: 97001: Physical Medicine and Rehabilitation--Change in Policy Number
A21409: J1563: Intravenous Immune Globulin
A21410: 2004 ICD-9-CM Part A Local Medical Review Policy Changes
A21411: 88142: Pap Smears--Revision to Policy
A21413: 83880: B-Type Natriuretic Peptide (BNP)--New Policy
A21417: 20974: Osteogenic Stimulation--Addition to Policy
A21418: 33215: Implantation of Automatic Defibrillators--Revision to Policy
A21419: 70551: Magnetic Resonance Imaging of the Brain--Addition to Policy
A21420: 29540: Strapping--Addition to Policy
A21423: 44388 Colonoscopy--Revision to Policy
A21425: 76092: Screening Mammograms--Revision to Policy
A21426: 77750: Clinical Brachytherapy--Revision to Policy
A21427: 95805: Sleep Testing--Revision to Policy
A21428: 92235: Fluorescein angiography--Revision to Policy
A21429: 94799: Pulmonary Rehabilitation--Retirement of Policy
A21430: 97001: Physical Medicine and Rehabilitation--Revision to Policy
A21431: A4644: Low Osmolar Contrast Media--Retirement of Policy
A21432: A0425: Ground Ambulance Services--Revision to Policy
A21433: C1300: Hyperbaric Oxygen Therapy (HBO Therapy)--Revision to Policy
A21437: G0104: Colorectal Cancer Screening--Revision to Policy
A21438: J0585: Botulinum Toxin Type A (Botox)--Addition to Policy
A21439: J1955: Levocarnitine (Carnitor, L-carnitine)--Revision to Policy
A21440: G0108: Diabetes Outpatient Self-Management Training--Revision to Policy
A21441: NESP: Darbepoetin alfa (Aranesp) (novel erythropoiesis stimulating protein [NESP]) (formerly J0880)--Revision to Policy
A21443: Correct Billing of Darbepoetin alfa (Aranesp) (novel erythropoiesis stimulating protein [NESP])
A21444: PHPPROG: Psychiatric Partial Hospitalization Program--Revision to Policy
A21445: 2004 HCPCS Local Medical Review Policy Changes
A21446: Billing for Internet Surveillance of an Implanted Cardioverter Defibrillator Without Face-to-Face Contact
A23481: 15822: Upper Eyelid and Brow Procedures—New Policy
A23482: ALEFACEPT—New Policy
A23484: BEXXAR: Tositumomab and Iodine I 131 Tositumomab (BEXXAR®) Therapy—New Policy
A23485: PULMDIAGSVCS: Pulmonary Diagnostic Services—New Policy
A23486: 43235: Diagnostic and Therapeutic Esophagogastroduodensocopy—Addition to Policy
A23487: 80100: Qualitative Drug Screen—Revision to Policy
A23488: 92135: Scanning Computerized Ophthalmic Diagnostic Imaging—Revision to Policy
A23492: 92225 Ophthalmoscopy—Revision to Policy
A23493: 93501: Cardiac Catheterization—Revision to Policy
A23494: 93724: Electronic Analysis of Pacemaker System and Pacer Cardioverter-Defibrillator—Revision to Policy
A23495: 93925: Duplex Scan of Lower Extremity Arteries—Revision to Policy
A23497: 97001: Physical Medicine and Rehabilitation—Revision to Policy
A23498: Botulinum Toxins (Formerly J0585 Botulinum Toxin Type A (Botox) and J0587 Botulinum Toxin Type B (Myobloc))—Revision to Policy
A23499: EPO: Epoetin alfa—Revision to Policy
A23500: G0104: Colorectal Cancer Screening—Revision to Policy
A23501: G0237: Respiratory Therapeutic Services—Revision to Policy
A23502: NESP: Darbepoetin alfa (Aranesp®) (novel erythropoiesis stimulating protein [NESP])—Revision to Policy
A23503: J0207: Amifostine (Ethyol®)—Revision to Policy
A23504: 93784: Ambulatory Blood Pressure Monitoring (ABPM)—Retirement of Policy
A23505: 94010: Spirometry—Retirement of Policy
A23507: 94620: Pulmonary Stress Testing—Retirement of Policy
A23508: Rho (D) Immune Globulin Intravenous
A23509: 92235: Fluorescein Angiography—Correction
A24453: Payment Limits for J7308 (Levulan Kerastick) and J9395 (Faslodex®)—Drug Pricing Update
A24454: Diabetes Self-Management Training Services
A24455: Sensory Nerve Conduction Threshold Test
A24456: Emergency Hospital Outpatient Billing of Epotein Alfa (EPO) and Darbepoetin Alfa (Aranesp®)
A24457: 32491: Lung Volume Reduction Surgery (LVRS)—New Policy
A24458: 29540: Strapping—Revision to Policy
A24459: 33215: Implantation of Automatic Defibrillators—Revision to Policy
A24460: 67221: Ocular Photodynamic Therapy (OPT) with Verteporfin—Revision to Policy
A24461: 70544: Magnetic Resonance Angiography (MRA)—Addition to Policy
A24462: 76536: Ultrasound, Soft Tissues of Head and Neck—Revision to Policy
A24463: 93501: Cardiac Catheterization—Revision to Policy
A24464: 93701: Cardiac Output Monitoring by Thoracic Electrical Bioimpedance—Revision to Policy
A24465: 93975: Duplex Scanning—Addition to Policy
A24466: NESP: Darbepoetin alfa(Aranesp®)(novel erythropoiesis stimulating protein [NESP])—Revision to Policy
A24468: C1300: Hyperbaric Oxygen Therapy (HBO Therapy)—Revision to Policy
A24469: G0104: Colorectal Cancer Screening—Revision to Policy
A24470: G0108: Diabetes Outpatient Self-Management Training—Revision to Policy
A24471: J1563: Intravenous Immune Globulin—Revision to Policy
A24472: J2916: Ferrlecit®—Revision to Policy
A24473: J9000: Antineoplastic Drugs—Revision to Policy
A24474: Zevalin: Ibritumomab Tiuxetan (ZevalinTM) Therapy—Revision to Policy
A24475: PAINREH: Pain Rehabilitation—Retirement of Policy
A24476: 92135: Scanning Computerized Ophthalmic Diagnostic Imaging—Correction to Previously Published Article
A24477: 93501: Cardiac Catheterization—Correction to Previously Published Article
A24478: EPO: Epoetin alfa and J0207: Amifostine (Ethyol®)—Correction to Previously Published Article
A24479: Ambulance Transports to and from a Diagnostic or Therapeutic Site other than a Hospital—Change to the Skilled Nursing Facility Consolidated Billing Edits
A24970: CMS and FCSO Offer Help to Address Potential Medicare Billing and Payment Impacts Due to 2004 Hurricanes
A24971: Ambulance Transports Related to Hurricane Evacuations
A24973: Billing Instructions for ADVATE rAHF-PFM on Medicare Claims
A24975: A11000: Debridement Services—New Policy
A24976: AAPBI: Accelerated Partial Breast Irradiation—New Policy
A24978: A90804: Individual Psychotherapy-Revision to Policy
A24979: A90810: Interactive Individual Psychotherapy - Revision to Policy
A24981: A90847: Family Psychotherapy - Revision to Policy
A24982: A90853: Group Psychotherapy - Revision to Policy
A24983: A90857: Interactive Group Psychotherapy - Revision to Policy
A24984: A90901: Biofeedback - Revision to Policy
A24985: A90901: Biofeedback - Revision to policy
A24986: A92135: Scanning Computerized Ophthalmic Diagnostic Imaging - Revision to Policy
A25275: A93303: Transthoracic and Doppler Echocardiography and Doppler Color Flow Velocity Mapping - Revision to Policy
A25276: A97003: Occupational Therapy Policy for Rehabilitation Services - Addition to Policy
A25277: AEPO - Epoetin alfa - Revision to Policy
A25278: AG0166: External Counterpulsation - Revision to Policy
A25279: AJ0640: Leucovorin (Wellcovorin(R)) - Revision to Policy
A25280: AJ2792: Rho (D) Immune Globulin Intravenous - Revision to Policy
A25281: AJ2430: Pamidronate (Aredia(R), APD) - Revision to Policy
A25282: AMAHD/ER: Metabolically Active Human Dermal/Epidermal Replacements - Revision to Policy
A25284: ANESP: Darbepoetin alfa (Aranesp(R)) (novel erythropoiesis stimulating protein [NESP]) - Revision to Policy
A25285: APHPPROG: Psychiatric Partial Hospitalization Program - Revision to Policy
A25286: APULMDIAGSVCS: Pulmonary Diagnostic Services - Revision to Policy
A25287: AVISCO: Viscosupplementation Therapy for Knee - Revision to Policy
A25288: A93701: Cardiac Output Monitoring by Thoracic Electrical Bioimpedance - Correction to Previously Published Article
A25289: AJ9000: Antineoplastic Drugs - Correction to Previously Published Article
A25290: Multiple Policies Being Retired
A25291: A95805: Sleep Testing - Retirement of Policy
A25292: Self Adminsitered Drugs and Biologicals - Addition to Established List
A25295: 2005 ICD-9-CM Changes
A25305: Inpatient Psychiatric Hospital Services - Widespread Probe Review Results
A25306: CPT Codes 72100, 72170, 73030, and 73510 - Widespread Probe Review Results
A25307: Inpatient Rehabilitation Facility - Widespread Prove Review Results
A34265: Medical Review Process Revision to Medical Record Requests
A34266: Intravenous Iron Therapy
A34267: Replacement of Prosthetic Devices and Parts
A34268: Intestinal Transplantation
A34313: Off Label Use of Oral Chemotherapy Drugs Methotrexate and Cyclophosphamide
A34314: Ultrasonic Osteogenic Stimulator
A34315: Additional Coverage for Autologous Stem Cell Transplantation
A34316: Coverage of Noninvasive Vascular Studies for End Stage Renal Disease (ESRD) Patients
A34317: Screening Glaucoma Services
A34318: Coverage and Billing of Sacral Nerve Stimulation
A34319: Screening Services vs. Diagnostic Services
A34320: Coverage and Billing of Biofeedback Training for the Treatment of Urinary Incontinence
A34321: Expansion of Coverage on Percutaneous Transluminal Angioplasty
A34322: Intravenous Iron Therapy
A34323: Medicare Coverage of Drugs and Biologicals, Payment Methodologies, and Ehtical Obligations of Health Care Professionals
A34324: Intestinal and Multi-Visceral Transplantation
A34325: Verteporfin
A34326: Expanded Coverage pf Positron Emission Tomography (PET) Scans and Related Claims Processing Changes
A34327: 70544: Magnetic Resonance Angiography – Revision to Policy
A34328: 82728: Serum Ferritin—Revision to Policy
A34329: J1561: Intravenous Immune Globulin - Addition to POlicy
A34330: 82435: Chloride – Correction to Policy
A34331: 94010: Spirometry – Revision to Policy
A34332: J9999: Doxorubicin HCL – Revision to Antineoplastic Drugs Policy
A34333: Local Medical Review Policy Development Changes
A34539: Submission of Rural Air Ambulance Service Protocol for Contractor Review
A34540: A11000: Debridement Services—Revision to Policy
A34541: A22899: Kyphoplasty—Revision to Policy
A34542: A76090: Diagnostic Mammography—Revision to Policy
A34543: A76092: Screening Mammograms—Revision to Policy
A34544: ABotulinum Toxins: Botulinum Toxins—Revision to Policy
A34545: AEPO: Epoetin alfa—Revision to Policy
A34546: AJ0207: Amifostine (Ethyol®)—Revision to Policy
A34547: AJ1563: Intravenous Immune Globulin—Revision to Policy
A34548: AJ9000: Antineoplastic Drugs—Addition to Policy
A34549: APULMDIAGSVCS: Pulmonary Diagnostic Services—Addition to Policy
A34550: ASKINSUB: Skin Substitutes—Revision to Policy
A34551: AVISCO: Viscosupplementation Therapy for Knee—Addition to Policy
A34552: Ambulance Services—Retirement of Policies
A34553: Clarification of Psychotherapy Documentation Requirements
A38982: A70544: Magnetic Resonance Angiography (MRA)—Revision to Policy
A38983: A72192: Computed Tomography of the Pelvis—Addition to Policy
A38984: A76070: Bone Mineral Density Studies—Revision to Policy
A38985: A85651: Sedimentation Rate, Erythrocyte—Revision to Policy
A38986: AEPO: Epoetin alfa—Revision to Policy
A38987: AG0030: Positron Emission Tomography (PET) Scans—Revision to Policy
A38988: AG0237: Respiratory Therapeutic Services—Revision to Policy
A38989: AJ2820: Sargramostim (GM-CSF, Leukine®)—Revision to Policy
A38990: AJ3487: Zoledronic Acid (Zometa®)—Revision to Policy
A38991: AJ9000: Antineoplastic Drugs—Addition to Policy
A38993: AJ9293: Mitoxantrone Hydrochloride—Revision to Policy
A38994: ANESP: Darbepoetin Alfa (Aranesp®)—Revision to Policy
A38995: Multiple Policies Being Revised—Revision to Policies
A38996: A33216: Implantation of Automatic Defibrillators—Retirement of Policy
A38997: A94760: Noninvasive Ear or Pulse Oximetry for Oxygen Saturation—Retirement of Policy
A38999: AG0245: Peripheral Neuropathy with Loss of Protective Sensation (LOPS) in People with Diabetes—Retirement of Policy
A39000: AG0248: Home Prothrombin Time International Normalized Ratio (INR) Monitoring—Retirement of Policy
A39002: AJ1950: Leuprolide Acetate—Retirement of Coding Guidelines
A39217: A0067T: Computed Tomographic Colonography—New Determination
A39220: A92548: Computerized Dynamic Posturography—New Determination
A39221: AINPTPSYCH: Psychiatric Inpatient Hospitalization—New Determination
A39222: AIRF: Inpatient Rehabilitation Facilities—New Determination
A39223: AJ0128: Abarelix for the Treatment of Prostate Cancer—New Determination
A39224: AJ9041: Bortezomib (Velcade®)—New Determination
A39225: A17304: Mohs Micrographic Surgery (MMS)—Revision to Policy
A39226: A70450: Computed Tomography Scans—Revision to Policy
A39227: A70551: Magnetic Resonance Imaging of the Brain—Revision to Policy
A39228: A72192: Computed Tomography of the Pelvis—Revision to Policy
A39229: A72192: Computed Tomography of the Abdomen and Pelvis—Revision to Policy
A39230: A77301: Intensity Modulated Radiation Therapy (IMRT)—Revision to Policy
A39231: A82310: Total Calcium—Revision to Policy
A39232: A82330: Ionized Calcium—Revision to Policy
A39233: A83970: Parathormone (Parathyroid Hormone)—Revision to Policy
A39234: A84100: Serum Phosphorus—Revision to Policy
A39235: A92506: Speech-Language Pathology Services; A97001: Physical Medicine and Rehabilitation; A97003: Occupational Therapy Policy for Rehabilitation Services; A97110: Complex Decongestive Physiotherapy—Revision to Policies
A39236: A95934: H-Reflex Study—Revision to Policy
A39237: AJ0640: Leucovorin (Wellcovorin®)—Revision to Policy
A39238: AJ2430: Pamidronate (Aredia®)—Revision to Policy
A39239: AJ2916: Ferrlecit® and Venofer®—Revision to Policy
A39240: AJ3487: Zoledronic Acid (Zometa®)—Revision to Policy
A39241: AJ9000: Antineoplastic Drugs—Revision to Policy
A39242: AOOS: Outpatient Observation Services—Revision to Policy
A39243: AQ9941: Intravenous Immune Globulin—Revision to Policy
A39244: ATHERSVCS: Therapy and Rehabilitation Services—Revision to Policy
A39245: A20974: Osteogenic Stimulation—Retirement of Policy
A39246: A76092: Screening Mammograms—Retirement of Policy
A39247: A82784: Gammaglobulin (Immunoglobulins); IgA, IgD, IgG, IgM, Each— Retirement of Policy
A39248: A84152: Complexed and Free Prostate Specific Antigen—Retirement of Policy
A39249: A93015: Cardiovascular Stress Test—Retirement of Policy
A39250: AJ0150: Adenosine (Adenocard®, Adenoscan®)—Retirement of Policy
A39251: Multiple Policies Being Retired
A39252: Local Medical Review Policy to Local Coverage Determination Conversion
A39253: ASKINSUB: Skin Substitutes—Coding Guidelines
A39254: Stereotactic Radiosurgery and Stereotactic Radiotherapy—Coding Guide
A39255: Review of ICD-9-CM Coding for HIV Testing: Diagnostic Codes and Prognosis/Monitoring Codes
A39256: AJ2324: Draft LCD for Nesiritide (Natrecor®) Infusion for Chronic Congestive Heart Failure—New Draft Policy
A40266: Medicare Part B Coverage of Drugs and Biologicals – Special Focus on the Unlabeled Use of Anti-Cancer Drugs
A40267: Terminating Ambulance HCPCS Q3019 and Q3020
A40268: Medical Condition List for Ambulance Services
A40269: A11000: Debridement Services—Addition to LCD
A40270: A70450: Computed Tomography Scans—Revision to LCD
A40271: A71250: Computed Tomography of the Thorax—Revision to LCD
A40272: A76070: Bone Mineral Density Studies—Revision to LCD
A40273: A90804: Individual Psychotherapy—Revision to LCD
A40274: A90853: Group Psychotherapy—Revision to LCD
A40275: A92081 Visual Field Examination—Revision to LCD
A40276: A92225: Ophthalmoscopy—Revision to LCD
A40277: A93922: Non-Invasive Physiologic Studies of Upper or Lower Extremity Arteries - Revision to LCD
A40278: A93925: Duplex Scan of Lower Extremity Arteries—Revision to LCD
A40279: A93965: Non-Invasive Evaluation of Extremity Veins—Revision to LCD
A40280: AC1300: Hyperbaric Oxygen Therapy (HBO Therapy)—Revision to LCD
A40281: ADYSPHRT: Dysphagia/Swallowing Diagnosis and Therapy—Revision to Policy
A40282: AEPO: Epoetin alfa—Revision to LCD
A40283: AG0117: Screening Glaucoma Services—Retirement of Policy
A40284: AJ9000: Antineoplastic Drugs—Addition to LCD
A40285: ANESP: Darbepoetin alfa (Aranesp®) (novel erythropoiesis stimulating protein [NESP]) - Revision to LCD
A40286: AVISCO: Viscosupplementation Therapy for Knee—Revision to LCD
A40287: Multiple Policies Being Retired
A40288: A80100: Qualitative Drug Screen—Retirement of Policy
A40289: Prostate Specific Antigen Correct Coding: Use G0103 for Screening Exams
A40434: Requirements for the Payment of Medicare Claims - A Selection of Some Important Criteria
A40435: A11000: Debridement Services—Revision to the LCD
A40436: A17304: Mohs Micrographic Surgery (MMS)—Addition to the LCD
A40437: A32491: Lung Volume Reduction Surgery—Revision to the LCD
A40438: A72141: Magnetic Resonance Imaging of the Spine—Revision to the LCD
A40439: A93303: Transthoracic Echocardiography (TTE)—Addition to the LCD
A40440: AEPO: Epoetin alfa—Revision to the LCD
A40441: AJ0640: Leucovorin (Wellcovorin®)—Revision to the LCD
A40442: AJ1745: Infliximab (Remicade®)—Revision to the LCD
A40443: AJ2430: Pamidronate (Aredia®, APD)—Revision to the LCD
A40444: AJ2505: Pegfilgrastim (Neulasta®)—Revision to the LCD
A40445: AJ9000: Antineoplastic Drugs—Revision to the LCD
A40446: ANESP: Darbepoetin alfa (Aranesp®) (novel erythropoiesis stimulating protein [NESP]) - Revision to LCD
A40447: AOOS: Outpatient Observation Services —Revision to the LCD
A40448: ATHERSVCS: Therapy and Rehabilitation Services—Revision to the LCD
A40449: Stereotactic Radiosurgery and Stereotactic Radiotherapy—Correction to a previously published article
A40450: Intravitreal Bevacizumab (Avastin®) for Neovascular Age-Related Macular Degeneration
A40451: Vagal Nerve Stimulation for Intractable Depression
A40452: Vertebral Fracture Assessment—CPT Code 76077
A40453: Wireless Capsule Endoscopy of the Esophagus
A40454: AAPBI: Accelerated Partial Breast Irradiation (APBI)—Correction to a Previously Published Article
A40455: New HCPCS Codes for Reporting Hemophilia Clotting Factor Services
A40456: Submission of Hemophilia Clotting Factor Claims
A40977: Medicare Secondary Payer
A41303: Billing Clarification for Pegfilgrastim—HCPCS Code J2505
A41304: Issue with Code Pair Edit 92526/G0283 Under the Correct Coding Initiative
A41305: Inconsistency in Liability Assignment for Screening Services
A41306: Temporary Hold of Pancreas Transplantation Alone Claim Submission
A41307: Hospital Payment Information for Certain Elective Procedures and Admissions
A41308: Ambulance Claims Submitted by Critical Access Hospitals
A41317: May Is National Osteoporosis Awareness and Prevention Month
A41318: National Men's Health Week
A41500: AJ7504: ATGAM (Lymphocyte Immune Globulin, Antithymocyte Globulin [Equine]) - New LCD
A41502: A93798: Cardiac Rehabilitation Programs—Addition to the LCD
A41503: ABotulinum Toxins—Revision to the LCD
A41504: AEPO: Epoetin alfa—Revision to the LCD
A41505: AG0104: Colorectal Cancer Screening—Addition to the LCD and Coding Guideline
A41506: AINPTPSYCH: Psychiatric Inpatient Hospitalization—Revision to the LCD
A41507: AJ9000: Antineoplastic Drugs—Revision to the LCD
A41508: ANESP: Darbepoetin alfa (Aranesp®) (novel erythropoiesis stimulating protein [NESP]) - Revision to LCD
A41510: ATHERSVCS: Therapy and Rehabilitation Services—Revision to the LCD
A41511: Intravitreal Bevacizumab (Avastin®) for Neovascular Age-Related Macular Degeneration - Revised
A42602: A36470: Treatment of Varicose Veins of the Lower Extremities—New LCD
A42603: A61885: Vagal Nerve (VNS) Stimulation for Intractable Depression— New LCD
A42604: A82550: Creatine Kinase (CK), (CPK)—New LCD
A42605: A86803: Hepatitis C Antibody in the ESRD and non-ESRD Setting—New LCD
A42606: A0145T Computed Tomographic Angiography of the Chest, Heart and Coronary Arteries - New LCD
A42607: AJ0740: Ganciclovir and Cidofovir—New LCD
A42608: AJ1080: Testosterone Cypionate and Testosterone Enanthate—New LCD
A42609: AJ2325: Nesiritide (Natrecor®)—New LCD
A42610: AJ9213: Interferon, alpha 2-a (Roferon®-A)—New LCD
A42611: A43235: Diagnostic and Therapeutic Esophagogastroduodenoscopy— Addition to LCD
A42612: A78459: Myocardial Imaging, Positron Emission Tomography (PET) Scan— Revision to LCD
A42613: A91110: Wireless Capsule Endoscopy—Revision to the LCD
A42614: A93875: Non-invasive Extracranial Arterial Studies—Addition to the LCD
A42615: A0067T: Computed Tomographic Colonography—Revision to the LCD
A42616: AJ1566: Intravenous Immune Globulin—Revision to the LCD
A42617: AJ2505: Pegfilgrastim (Neulasta®)—Coding Guideline Addition
A42618: AJ9000: Antineoplastic Drugs—Correction to the LCD
A42620: AJ9000: Antineoplastic Drugs—Revision to the LCD
A42621: AJ9015: Aldesleukin (Proleukin®, Interleukin-2, Recombinant, and RIL-2)— Revision to LCD
A42622: ASKINSUB: Skin Substitutes—Revision to the LCD
A42623: AVISCO: Viscosupplementation Therapy for Knee—Revision to the LCD
A42624: LucentisTM (ranibizumab injection) for Neovascular Age-Related Macular Degeneration
A42834: A93965: Non-Invasive Evaluation of Extremity Veins—Addition to the LCD
A42835: ABotulinum Toxins—Revision to the LCD
A42836: AEPO: Epoetin alfa—Revision to the Coding Guideline
A42837: AJ1950: Luteinizing Hormone-Releasing Hormone (LHRH) Analogs— Revision to the LCD and Coding Guideline
A42838: ANESP: Darbepoetin alfa (Aranesp®) (novel erythropoiesis stimulating protein [NESP])—Revision to the Coding Guideline
A42839: ATHERSVCS: Therapy and Rehabilitation Services—Addition to the LCD
A42840: A43235: Diagnostic and Therapeutic Esophagogastroduodenoscopy— Correction to Previously Published Article
A42841: J2354: Octreotide Acetate Injection (Sandostatin®) Removed from Self- administered Drug (SAD) List
A42842: Administration of Certain Biological Reponse Modifiers
A43378: AJ2430: Pamidronate (Aredia®)—Revision to the LCD
A43379: AJ9000: Antineoplastic Drugs—Revision to the LCD
A43380: Billing for Ground Ambulance Services when the Beneficiary Is Pronounced Deceased
A43381: New 2007 Current Procedural Terminology Codes for Mammography Services
A43383: Holding Claims for Diagnostic and/or Screening Mammography Services on Type of Bill 13x
A43384: A84484: Troponin—Addition to the LCD
A43385: AEPO: Epoetin alfa—Revision to the LCD
A43386: AJ1745: Infliximab (Remicade®)—Revision to the LCD
A43387: AJ9000: Antineoplastic Drugs—Revision to the LCD
A43389: ANESP: Darbepoetin alfa (Aranesp®) (novel erythropoiesis stimulating protein [NESP]) - Revision to the LCD
A43390: APULMDIAGSVCS: Pulmonary Diagnostic Services—Revision to the LCD
A43391: A77520: Draft LCD for Proton Beam Radiotherapy Not Finalized
A43392: A90802: Interactive Psychiatric Services—New LCD
A43393: ANCSVCS: The List of Medicare Noncovered Services—New LCD
A43394: A76070 Bone Mineral Density Studies - Revision to the LCD
A43395: ABotulinum Toxins—Revision to the LCD
A43396: AEPO: Epoetin alfa—Revision to the Coding Guideline
A43397: ANESP: Darbepoetin alfa (Aranesp®) (novel erythropoiesis stimulating protein [NESP]) - Revision to the Coding Guideline
A43437: AJ9000: Antineoplastic Drugs—Addition to the LCD
A43438: ATHERSVCS: Therapy and Rehabilitation Services—Revision to the LCD and Coding Guideline
A43439: 2007 HCPCS Local Coverage Determination Changes
A43440: List of Procedures Approved in an Ambulatory Surgical Center
A43516: AJ9000: Antineoplastic Drugs—Addition to the LCD
A43521: AJ9041: Bortezomib (Velcade®)—Revision to the LCD
A43522: ATHERSVCS: Therapy and Rehabilitation Services—Revision to the LCD
A43523: AVISCO: Viscosupplementation Therapy for Knee—Revision to the LCD
A43525: Blood Glucose Monitoring Services
A43526: Elimination of the Manual Process for Therapy Cap Exceptions
A43659: AJ2505: Pegfilgrastim (Neulasta®)—Revision to the LCD
A43660: AJ9041: Bortezomib (Velcade®)—Revision to the LCD
A43661: ANCSVCS: The List of Medicare Noncovered Services—Addition to the LCD
A43662: AVISCO: Viscosupplementation Therapy for Knee—Revision to the LCD
A43663: CPT Code 99212—Widespread Probe Review Results
A44149: Medical Condition List and Instructions for Ambulance Services
A44156: Extracorporeal Photopheresis (CPT Code 36522)—National Coverage Guideline Clarification
A44158: Claims for Hemophilia Clotting Factor—HCPCS Code J7187
A44159: A72192: Computed Tomography of the Abdomen and Pelvis—Revision to the LCD
A44160: AEPO: Epoetin alfa—Revision to the LCD and Coding Guidelines
A44161: AJ9000: Antineoplastic Drugs—Addition to the LCD
A44162: ANESP: Darbepoetin alfa (Aranesp®) (novel erythropoiesis stimulating protein [NESP])—Revision to the LCD and Coding Guidelines
A44164: ANESP: Darbepoetin alfa (Aranesp®) (novel erythropoiesis stimulating protein [NESP])—Revision to the LCD
A44171: Screening and Noncovered Services
A45138: AJ0129: Abatacept—New LCD
A45139: A0145T: Computed Tomographic Angiography of the Chest, Heart and Coronary Arteries - Revision to the LCD
A45140: A93965: Non-Invasive Evaluation of Extremity Veins—Addition to the LCD
A45141: A95860: Electromyography and Nerve Conduction Studies (formerly A95900: Nerve Conduction Studies)—Revision to the LCD
A45143: A95934: H-Reflex Study—Retirement of the LCD
A45144: AEPO: Epoetin alfa—Revision to the LCD
A45145: AJ2505: Pegfilgrastim (Neulasta®)—Revision to the LCD
A45146: APULMDIAGSVCS: Pulmonary Diagnostic Services—Revision to the LCD
A45147: ATHERSVCS: Therapy and Rehabilitation Services—Revision to the LCD
A45148: ATHERSVCS: Therapy and Rehabilitation Services—Revision to the LCD
A45149: Revision to Billing Instructions for Hemophilia Clotting Factor Claims— HCPCS Code J7187
A45328: Therapy Services Rendered by Massage Therapists and Billed “Incident To”
A45329: Information Update Regarding Payment and Coding for Drugs and
A45330: AJ0740: Ganciclovir and Cidofovir—Revision to the LCD
A45331: AJ1440: G-CSF (Filgrastim, Neupogen®)—Revision to the LCD
A45332: AJ9000: Antineoplastic Drugs—Retired LCD and Individual Revised LCDs
A45681: A91110: Wireless Capsule Endoscopy—Revision to the LCD
A45682: AEPO: Epoetin alfa—Revision to the LCD
A45796: A64702: Surgical Decompression for Peripheral Polyneuropathy of Diabetes—New LCD
A45797: A0171T: Interspinous Process Decompression—New LCD
A45798: AJ9055: Cetuximab (Erbitux®)—New LCD
A45799: A77078: Bone Mineral Density Studies—Revision to the LCD
A45800: A95860: Electromyography and Nerve Conduction Studies—Revision to the Coding Guidelines
A45801: AG0108: Diabetes Outpatient Self-Management Training—Revision to the LCD
A45802: AJ0129: Abatacept—Revision to the LCD
A45803: AJ1566: Intravenous Immune Globulin—Revision to the LCD
A45804: AJ2792: Rho (D) Immune Globulin Intravenous—Revision to the LCD
A45805: AJ9000: Doxorubicin HCl—Revision to the LCD
A45806: AJ9206: Irinotecan (Camptosar®)—Revision to the LCD
A45807: ANCSVCS: The List of Medicare Noncovered Services—Revision to the LCD
A45808: AVISCO: Viscosupplementation Therapy For Knee—Revision to the LCD
A46007: A93875: Non-invasive Extracranial Arterial Studies—Addition to the LCD
A46008: A93922: Noninvasive Physiologic Studies of Upper or Lower Extremity Arteries - Addition to the LCD
A46009: A93925: Duplex Scan of Lower Extremity Arteries—Addition to the LCD
A46010: A93965: Non-Invasive Evaluation of Extremity Veins—Addition to the LCD
A46011: Descemet’s Stripping Endothelial Keratoplasty (DSAEK)—Coding and Billing
A46012: Vagal Nerve Stimulation (VNS) for Seizures and Resistant Depression
A46013: 2008 ICD-9-CM Changes
A46014: Humanitarian Use Device and Humanitarian Device Exemptions
A46015: Investigational Device Exemptions
A46036: Billing Issues
A46248: AJ0129: Abatacept—Revision to the LCD
A46249: A55876: Implanted Fiducial Markers—Coding and Billing Guidelines
A46250: Diagnostic Breath Analysis—Coverage Guidelines
A46510: AJ2778: Ranibizumab (Lucentis®)—New LCD
A46511: AJ9025: Azacitidine (Vidaza®)—New LCD
A46512: AJ9305: Pemetrexed—New LCD
A46514: A90901: Biofeedback—Revision to LCD
A46515: A93875: Non-invasive Extracranial Arterial Studies—Revision to LCD
A46534: AEPO: Epoetin alfa—Revision to LCD
A46537: AJ1561: Intravenous Immune Globulin—Revision to LCD
A46540: AJ3487: Zoledronic Acid (Zometa®)—Revision to LCD
A46541: AJ9055: Cetuximab (Erbitux®)—Revision to LCD
A46549: AJ9178: Epirubicin Hydrochloride (Ellence®)—Revision to LCD
A46550: AJ9181: Etoposide (Etopophos®, Toposar®, Vepesid®, VP-16)—Revision to LCD
A46552: AJ9185: Fludarabine (Fludara®)—Revision to LCD
A46553: AJ9200: Floxuridine (FUDR)—Revision to LCD
A46554: AJ9201: Gemcitabine (Gemzar®)—Revision to LCD
A46556: AJ9265: Paclitaxel (Taxol®)—Revision to LCD
A46561: AJ9280: Mitomycin (Mutamycin®, Mitomycin-C)—Revision to LCD
A46562: AJ9310: Rituximab (Rituxan®)—Revision to LCD
A46563: AJ9390: Vinorelbine Tartrate (Navelbine®)—Revision to LCD
A46564: AJ9395: Fulvestrant (Faslodex®)—Revision to LCD
A46565: AJ9600: Porfimer (Photofrin®)—Revision to LCD
A46567: ANCSVCS: The List of Medicare Noncovered Services—Revision to LCD
A46568: ANESP: Darbepoetin alfa (Aranesp®) (novel erythropoiesis stimulating protein [NESP]) - Revision to LCD
A46569: 2008 HCPCS Local Coverage Determination Changes
A46570: AJ0881: Erythropoietin Stimulating Agents (ESAs)—Draft LCD Implementation Delayed
A46571: Electrocardiogram, 64 Leads or Greater—Coverage Guidelines
A46765: A93303: Transthoracic Echocardiography (TTE)—Revision to LCD
A46766: ATHERSVCS: Therapy and Rehabilitation Services—Revision to LCD
A46767: AJ1440: G-CSF (Filgrastim, Neupogen®)—Clarification on Correct Administration of Neupogen
A46768: CPT Code 99211: Widespread Probe Review Results
A47599: AJ0881: ERYTHROPOIESIS STIMULATING AGENTS—REVISION TO LCD
A47602: AJ9170: DOCETAXEL (TAXOTERE®)—REVISION TO THE LCD
A47603: AJ9355: TRASTUZUMAB (HERCEPTIN®)—REVISION TO THE LCD
A47604: COVERAGE FOR THREE-D RENDERING CPT CODES 76376 AND 76377
A47701: A51784: Anorectal Manometry and EMG of the Urinary and Anal Sphincters - New LCD
A47702: A87181: Susceptibility Studies - New LCD
A47703: AJ1561: Intravenous Immune Globulin - Revision to the LCD
A47704: AJ9310: Rituximab (Rituxan®) - Revision to the LCD
A47705: ANCSVCS: The List of Medicare Noncovered Services - Revision to the LCD
A47707: AVISCO: Viscosupplementation Therapy for Knee - Revision to the LCD
A47709: A77371: Stereotactic Radiosurgery (SRS) - Draft LCD
A47710: AG0173: Stereotactic Body Radiation Therapy (SBRT) - Draft LCD
A47711: ATHERSVCS: Therapy and Rehabilitation Services - Revistion to the Coding Guidelines
A47712: ABOTULINUM TOXINS: Botulinum Toxins - Revision tot he Coding Guidelines
A47713: AJ1440: G-CSF (Filgrastim, Neupogen®): Clarification on Correct Adminsitration of Neupogen - Revision to article
A47783: AJ0129: ABATACEPT—REVISION TO THE LCD
A47876: AJ7187 HEMOPHILIA CLOTTING FACTORS—CODING GUIDELINES RETIRED
A47877: ATHERSERVCS: THERAPY AND REHABILITATION SERVICES—REVISION TO THE LCD
A47878: AJ0881: ERYTHROPOIESIS STIMULATING AGENTS—CLARIFICATION ON CORRECT CODING OF ESAs
A47879: AJ0881: ERYTHROPOIESIS STIMULATING AGENTS—CLARIFICATION ON CORRECT CODING OF ESAs
A48077: A84999: Gene Expression Profiling Panel for use in the Management of Breast Cancer Treatment–New LCD
A48078: A93303: Transthoracic Echocardiography (TTE)-Revision to the LCD
A48079: A93312: Transesophageal Echocardiogram - Revision to the LCD
A48080: AG0237: Respiratory Therapeutic Services - Revision to the LCD
A48081: AJ9355: Trastuzumab (Herceptin) - Revision to the LCD
A48082: ANCSVCS: The List of Medicare Noncovered Services – Revision to the LCD
A48083: ANCSVCS: The List of Medicare Noncovered Services – Revision to the LCD
A48084: AVISCO: Viscosupplementation Therapy For Knee – Revision to the LCD
A48085: ATHERSVCS: Therapy and Rehabilitation Services: Revision to Coding Guidelines
A48086: AJ9025: VIDAZA and administration code 96401 - clarification of correct billing
A48111: ATHERSVCS: Therapy and Rehabilitation Services: Revision to the LCD and Coding Guidelines
A48116: 0192T: Aqueous Drainage Device for the Treatment of Glaucoma
A48117: AJ7187: Hemophilia Clotting Factors - Revision to the LCD
A48118: AJ9041: Bortezomib (Velcade®) - Revision to the LCD
A48146: 2009 ICD-9-CM changes
A48202: AZEVALIN: Ibritumomab tiuxetan (Zevalin TM) therapy – revision to the LC
A48203: AJ0881: Erythropoiesis stimulating agents – revision to the LCD
A48204: AJ0881: Erythropoiesis stimulating agents – revision to the coding guidelines
A48214: ASKINSUB: Skin substitutes - revision to the LCD
A48215: ASKINSUB: Skin substitutes - revision to the LCD
A48263: AJ2357: Omalizumab (Xolair) administration and 96401-clarification of correct billing
A48265: C9399: Triesence™ (triamcinolone acetonide injectable suspension)
A48305: J2505: Clarification on correct administration of Neupogen and Neulasta
A48311: AJ0881: Erythropoiesis stimulating agents–revision to the coding guidelines
A48350: 2009 HCPCS local coverage determination changes
A48627: APPHROG: Psychiatric partial hospitalization program- revision to the LCD
A48628: ANCSVCS: The list of Medicare noncovered services–revision to the LCD